Gaines Kristin S.'s most recent trade in National Health Investors, Inc. was a trade of 8,334 Stock Option (Right to Buy) 2025 done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 8,334 | 8,334 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 8,333 | 8,333 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 8,333 | 8,333 | - | - | Stock Option (Right to Buy) 2025 | |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 4,000 | 61,944 (0%) | 0% | 0 | Common Stock | |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.66 per share. | 25 Sep 2024 | 48,665 | 57,944 (0%) | 0% | 84.7 | 4,119,979 | Common Stock |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2024 | 18,334 | 0 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.20 per share. | 25 Sep 2024 | 18,334 | 106,609 (0%) | 0% | 69.2 | 1,268,713 | Common Stock |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.20 per share. | 25 Sep 2024 | 18,333 | 69,942 (0%) | 0% | 69.2 | 1,268,644 | Common Stock |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2024 | 18,333 | 0 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2024 | 18,333 | 0 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.20 per share. | 25 Sep 2024 | 18,333 | 88,275 (0%) | 0% | 69.2 | 1,268,644 | Common Stock |
| National Health Investors,... | S. Kristin Gaines | SVP/Chief Transaction Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 8,334 | 8,334 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors,... | Gaines Kristin S. | SVP/Chief Transaction Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 8,333 | 8,333 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 8,333 | 8,333 | - | - | Stock Option (Right to Buy) 2024 | |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 3,000 | 51,609 (0%) | 0% | 0 | Common Stock | |
| National Health Investors,... | Kristin S. Gaines | SVP/Chief Transaction Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 4,000 | 48,609 (0%) | 0% | 0 | Common Stock | |
| National Health Investors,... | Kristin S. Gaines | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 8,334 | 8,334 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | Kristin S. Gaines | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 8,333 | 8,333 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | Kristin S. Gaines | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 8,333 | 8,333 | - | - | Stock Option (Right to Buy) 2023 | |
| National Health Investors,... | Kristin S. Gaines | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 18,334 | 18,334 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | Kristin S. Gaines | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 18,333 | 18,333 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | Kristin S. Gaines | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 18,333 | 18,333 | - | - | Stock Option (Right to buy) 2022 | |
| National Health Investors,... | Kristin S. Gaines | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 18,334 | 18,334 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors,... | Kristin S. Gaines | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 18,333 | 18,333 | - | - | Stock Options (Right to Buy) 2-25-2021 | |
| National Health Investors,... | Kristin S. Gaines | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 18,333 | 18,333 | - | - | Stock Options (Right to Buy) 2-25-2021 |